In China, Drug Master Files (DMFs) for excipients are not mandatory but are encouraged to ensure quality and regulatory compliance. Manufacturers can submit DMFs voluntarily to provide detailed information about the excipient’s manufacturing process, quality control, and safety, facilitating smoother approval processes for pharmaceutical products using these excipients.
